Union Minister of State (Independent Charge) for Science & Technology and Earth Sciences, Dr Jitendra Singh laid the foundation stone of the National Skill Development Centre (NSDC), SAMARTH, and inaugurated the iDeA-NA BRIC-CDFD Technology Incubator at the DBT–BRIC Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad.

Addressing the gathering, the minister said that India is now scientifically and economically prepared to tackle complex health challenges through genomics, biotechnology and preventive healthcare. He emphasised that early detection and affordability remain the two biggest challenges in addressing genetic and rare diseases in the country.

Dr Singh further highlighted the need for a shift towards preventive and personalised healthcare, noting that advances in genomics and biotechnology are enabling more targeted, efficient and accessible treatment approaches.

The launch of SAMARTH and the technology incubator is expected to strengthen India’s life sciences ecosystem by creating a skilled workforce, fostering innovation and accelerating the translation of research into healthcare solutions.

Highlighting the government’s policy direction, the minister said that biotechnology and health have received unprecedented priority under Prime Minister Narendra Modi, with repeated emphasis from the ramparts of the Red Fort. He recalled the announcement of the Bio-E3 Policy during the Independence Day address, describing it as a catalyst that has sparked widespread interest among scientists, startups and young innovators across the country.

Dr Singh observed that India is witnessing rapid progress in genomics-led initiatives, including large-scale genome sequencing, paediatric genetic disease programmes and pioneering work in areas such as haemophilia. He said these efforts are preparing the healthcare system for an era of personalised treatment, where patients with similar conditions may require different therapeutic approaches.

Referring to the issue of rare diseases, the minister said that the introduction of India’s first National Policy for Rare Diseases in 2021 marked a major shift in the government’s approach, reflecting foresight and openness to scientific inputs. He highlighted that detection alone is not enough, and sustained treatment must also be made affordable for affected families. He also spoke about the integrated healthcare model being promoted by the government, including the institutionalisation of traditional systems through the Ministry of Ayush and the global recognition of yoga as a preventive health tool. He said that evidence-based integration of wellness practices with modern medicine has shown positive outcomes in managing lifestyle and metabolic disorders.

During the visit, Dr Singh also reviewed ongoing research and innovation activities at CDFD and appreciated initiatives such as genome sequencing programmes and outreach efforts aimed at public awareness. The minister said that communicating science in a language accessible to citizens, especially the youth, is essential for building trust and interest in biotechnology.

Highlighting India’s growing bio-economy, he said that the number of biotech startups has increased manifold over the years, while the sector’s contribution to the economy has seen a sharp rise. He added that the formation of the Biotechnology Research and Innovation Council (BRIC) has strengthened coordination among institutions, leading to high-impact research and industry collaboration.

The minister also underscored India’s leadership in vaccines and preventive healthcare, stating that indigenous innovations are now being deployed nationally and shared globally, reinforcing the country’s role in global health security.